HRSA-22-057: Rural Communities Opioid Response Program-Implementation
Closed
This grant is closed. A newer notice from the same program is forecast: Rural Maternity and Obstetrics Management Strategies Program (HRSA-27-047). Status: Expected deadline April 20, 2027. It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make about 50 awards worth $50.0 million in total. Applications closed on January 18, 2022.
From the official notice on Grants.gov, last changed January 12, 2022. Checked November 7, 2026.
- Total funding$50.0 million
- Expected awards50
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | October 15, 2021 |
|---|---|
| Deadline | January 18, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include all domestic public or private, non-profit or for-profit entities, including faith-based and community-based organizations, tribes, and tribal organizations. In addition to the 50 U.S. states, organizations in the District of Columbia, Guam, the Commonwealth of Puerto Rico, the Commonwealth of the Northern Mariana Islands, American Samoa, the U.S. Virgin Islands, the Federated State of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau may apply. The applicant organization may be located in an urban or rural area and should have the staffing and infrastructure necessary to oversee program activities, serve as the fiscal agent for the award, and ensure that local control for the award is vested in the targeted rural communities.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Rural Communities Opioid Response Program (RCORP) is a multi-year initiative by the Health Resources and Services Administration (HRSA) aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in high risk rural communities. This notice announces the opportunity to apply for funding under RCORP-Implementation. This funding opportunity, RCORP-Implementation, will advance RCORP’s overall goal by strengthening and expanding SUD/OUD prevention, treatment, and recovery services to enhance rural residents’ ability to access treatment and move towards recovery. Given the complex and multifaceted nature of SUD/OUD, as well as the need to secure community buy-in and generate adequate patient volume to sustain services, HRSA requires that applicants be part of broad, multi-sectoral consortia. HRSA expects that consortia funded by RCORP-Implementation will sustain the SUD/OUD-related services in rural areas made possible by this funding opportunity both during and beyond the period of performance. The target population for the award is: 1) individuals who are at risk for, have been diagnosed with, and/or are in treatment and/or recovery for OUD; 2) their families and/or caregivers; and 3) other community members1 who reside in HRSA-designated rural areas, as defined by the Rural Health Grants Eligibility Analyzer. In addition to this target population, applicants are encouraged to give special consideration to rural populations that have historically suffered from poorer health outcomes or health disparities, as compared to the rest of the rural population. The primary focus of the RCORP-Implementation award program is OUD. However, recognizing that many individuals with OUD use multiple substance and/or have other co-occurring conditions, consortia may also use RCORP-Implementation support to help address other SUD-related needs of the target population of individuals and families affected by OUD. Applicants should link any additional activities they propose to the needs of their target population and service area. Please note that no competitive advantage, funding priority, or preference is associated with proposing activities beyond the core/required activities outlined in the Program-Specific Instructions section of this NOFO.
Who has won Rural Healthcare Services Programs grants before
From fiscal 2021 to 2025, Rural Healthcare Services Programs (93.912) awarded $727 million across 1,490 grant awards, an average of $487,643 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Rural Health Resource Center | Minnesota | 3 | $58.6 million |
| University of North Dakota | North Dakota | 3 | $10.3 million |
| JBS International, Inc. | Maryland | 1 | $10.1 million |
| Arkansas Rural Health Partnership | Arkansas | 6 | $8.3 million |
| Rural Health Redesign Center Organization, Inc. | Pennsylvania | 3 | $7.9 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-047, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-057 still open?
No. It closed on January 18, 2022. A newer notice is forecast: HRSA-27-047, expected deadline April 20, 2027.
Who can apply for Rural Communities Opioid Response Program-Implementation?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rural Communities Opioid Response Program-Implementation?
Closed January 18, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $50.0 million in total across about 50 awards.
Who has won Rural Healthcare Services Programs grants before?
The largest recipients over five fiscal years were Rural Health Resource Center, University of North Dakota, JBS International, Inc. The program made 1,490 awards worth $727 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)